NO975862L - P-selektinligander og relaterte molekyler og fremgangsmåter - Google Patents

P-selektinligander og relaterte molekyler og fremgangsmåter

Info

Publication number: NO975862L
Authority: NO; Norway
Prior art keywords: methods; ligands; determinant; selectin ligands; related molecules
Prior art date: 1995-06-14

Application number

NO975862A

Other languages

English (en)

Norwegian (no)

Other versions

NO975862D0 (no

Inventor

Brian Seed

Tara Pouyani

Original Assignee

Gen Hospital Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-14

Filing date

1997-12-12

Publication date

1998-02-12

1997-12-12 Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp

1997-12-12 Publication of NO975862D0 publication Critical patent/NO975862D0/no

1998-02-12 Publication of NO975862L publication Critical patent/NO975862L/no

Links

239000003446 ligand Substances 0.000 title abstract 3
102000008212 P-Selectin Human genes 0.000 title abstract 2
108010035766 P-Selectin Proteins 0.000 title abstract 2
238000000034 method Methods 0.000 title abstract 2
206010001052 Acute respiratory distress syndrome Diseases 0.000 abstract 1
206010061218 Inflammation Diseases 0.000 abstract 1
208000013616 Respiratory Distress Syndrome Diseases 0.000 abstract 1
208000011341 adult acute respiratory distress syndrome Diseases 0.000 abstract 1
201000000028 adult respiratory distress syndrome Diseases 0.000 abstract 1
230000023555 blood coagulation Effects 0.000 abstract 1
210000004204 blood vessel Anatomy 0.000 abstract 1
230000003683 cardiac damage Effects 0.000 abstract 1
238000006243 chemical reaction Methods 0.000 abstract 1
102000037865 fusion proteins Human genes 0.000 abstract 1
108020001507 fusion proteins Proteins 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1
230000000302 ischemic effect Effects 0.000 abstract 1
230000008816 organ damage Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4727—Mucins, e.g. human intestinal mucin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/473—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used alpha-Glycoproteins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Gastroenterology & Hepatology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Toxicology (AREA)
Zoology (AREA)
Cell Biology (AREA)
Endocrinology (AREA)
Rheumatology (AREA)
Reproductive Health (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Diabetes (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

NO975862A 1995-06-14 1997-12-12 P-selektinligander og relaterte molekyler og fremgangsmåter NO975862L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US21395P	1995-06-14	1995-06-14
PCT/US1996/010043 WO1997000079A1 (en)	1995-06-14	1996-06-11	P-selectin ligands and related molecules and methods

Publications (2)

Publication Number	Publication Date
NO975862D0 NO975862D0 (no)	1997-12-12
NO975862L true NO975862L (no)	1998-02-12

Family

ID=21690430

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO975862A NO975862L (no)	1995-06-14	1997-12-12	P-selektinligander og relaterte molekyler og fremgangsmåter

Country Status (14)

Country	Link
EP (1)	EP0833650A4 (cs)
JP (1)	JPH11508131A (cs)
KR (1)	KR19990022954A (cs)
AR (1)	AR003436A1 (cs)
AU (1)	AU6272996A (cs)
BR (1)	BR9608918A (cs)
CA (1)	CA2224625A1 (cs)
CZ (1)	CZ401497A3 (cs)
HU (1)	HUP9901131A2 (cs)
IL (1)	IL122590A0 (cs)
NO (1)	NO975862L (cs)
TR (1)	TR199701620T1 (cs)
WO (1)	WO1997000079A1 (cs)
ZA (1)	ZA965032B (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999043834A2 (en) *	1998-02-27	1999-09-02	Genetics Institute, Inc.	P-selectin ligand protein, including tetrameric fusion proteins
EP1406930A4 (en) *	2000-12-29	2007-01-10	Savient Pharmaceuticals Inc	"ISOLATED MOLECULES WITH SULFATED GROUPING CONTAINING EPITOPES, ANTIBODIES AGAINST SUCH EPITOPES AND USES THEREOF"
JP4599027B2 (ja) *	2002-10-30	2010-12-15	東洋水産株式会社	Ｌ−セレクチン結合阻害剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE224911T1 (de) *	1990-07-17	2002-10-15	Univ Oklahoma	Gmp-140 ligand
US5318890A (en) *	1991-05-06	1994-06-07	The Regents Of The University Of California	Assays for inhibitors of leukocyte adhesion
AU681369B2 (en) *	1992-11-16	1997-08-28	Board Of Regents Of The University Of Oklahoma, The	Glycoprotein ligand for P-selectin and methods of use thereof
WO1995030001A2 (en) *	1994-04-28	1995-11-09	Genetics Institute, Inc.	Novel p-selectin ligand protein

1996
- 1996-06-11 JP JP9503258A patent/JPH11508131A/ja active Pending
- 1996-06-11 EP EP96921519A patent/EP0833650A4/en not_active Withdrawn
- 1996-06-11 CZ CZ974014A patent/CZ401497A3/cs unknown
- 1996-06-11 BR BR9608918A patent/BR9608918A/pt not_active Application Discontinuation
- 1996-06-11 HU HU9901131A patent/HUP9901131A2/hu unknown
- 1996-06-11 IL IL12259096A patent/IL122590A0/xx unknown
- 1996-06-11 WO PCT/US1996/010043 patent/WO1997000079A1/en not_active Ceased
- 1996-06-11 CA CA002224625A patent/CA2224625A1/en not_active Abandoned
- 1996-06-11 AU AU62729/96A patent/AU6272996A/en not_active Abandoned
- 1996-06-11 KR KR1019970709424A patent/KR19990022954A/ko not_active Withdrawn
- 1996-06-11 TR TR97/01620T patent/TR199701620T1/xx unknown
- 1996-06-13 AR ARP960103147A patent/AR003436A1/es unknown
- 1996-06-13 ZA ZA965032A patent/ZA965032B/xx unknown
1997
- 1997-12-12 NO NO975862A patent/NO975862L/no unknown

Also Published As

Publication number	Publication date
JPH11508131A (ja)	1999-07-21
BR9608918A (pt)	1999-06-15
NO975862D0 (no)	1997-12-12
WO1997000079A1 (en)	1997-01-03
AR003436A1 (es)	1998-08-05
HUP9901131A2 (hu)	1999-07-28
ZA965032B (en)	1997-03-14
EP0833650A4 (en)	2005-01-19
CA2224625A1 (en)	1997-01-03
AU6272996A (en)	1997-01-15
CZ401497A3 (cs)	1998-07-15
TR199701620T1 (xx)	1998-05-21
KR19990022954A (ko)	1999-03-25
IL122590A0 (en)	1998-06-15
EP0833650A1 (en)	1998-04-08

Publication	Publication Date	Title
US5811005A (en)	1998-09-22	Apparatus for intravenous administration of solutions of cell-free hemoglobin including a nitroxide bound to a matrix
Edwards et al.	1986	Haptoglobin-haemoglobin complex in human plasma inhibits endothelium dependent relaxation: evidence that endothelium derived relaxing factor acts as a local autocoid
Feinstein et al.	1969	Conformation of the free and antigen-bound IgM antibody molecules
Perutz	1972	Nature of haem–haem interaction
DK0710228T3 (da)	1998-09-21	Hydraziner med N3S-konfiguration som radionuclidchelatorer
CA2111092A1 (en)	1992-12-10	Specifically Beta-Beta Cross-Linked Hemoglobins and Method of Preparation
Nieuwenhuizen	2001	Fibrin‐mediated plasminogen activation
DE3853923D1 (de)	1995-07-06	Kationisierte antikörper für das austragen durch die blut-gehirn-schranke.
ES427365A1 (es)	1976-07-16	Un metodo de aislamiento de uno al menos de los factores decoagulacion de la sangre: fibrinogeno, factor viii antihe- mofilia y factor b.
WO1994029351A3 (en)	1994-12-22	Antibodies
DK0413188T3 (da)	1995-03-27	Fremgangsmåde til fremstilling af umodificerede, intravenøst administrerbare IgM- og/eller IgA-holdige immunglobulinpræparater
ATE158082T1 (de)	1997-09-15	Bestimmung von peptidmotiven auf mhc-molekülen
NO176807C (no)	1995-05-31	Sammensmeltet gen som koder for et hybridprotein, samt fremgangsmåte for fremstilling av et hybridprotein som kodes av et sammensmeltet gen; vektor og sammensmeltet gen
DE3667290D1 (de)	1990-01-11	Boronsaeureaddukte von technetium-99m-dioximkomplexen.
SE8301795L (sv)	1983-03-30	Plasminogenaktivatorkomplex
NO993151L (no)	1999-06-24	Fremgangsmåte for fremstilling av renset dimer av benavledet faktor
EP0393895A3 (en)	1991-03-13	Silicometallate molecular sieves and their use as catalysts in oxidation of alkanes
DK369287D0 (da)	1987-07-15	Immunotoksiner og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende dem
Kavanaugh et al.	1988	Affinity labeling of hemoglobin with 4, 4'-diisothiocyanostilbene-2, 2'-disulfonate: covalent cross-linking in the 2, 3-diphosphoglycerate binding site
Guillochon et al.	1981	Studies on haemoglobin immobilized by cross-linking with glutaraldehyde cross-lInked soluble polymers and artificial membranes
DK0629238T3 (da)	2000-12-18	Autotaxin:Motilitetsstimulerende protein, som er nyttigt til cancerdiagnose og terapi
Parkhurst et al.	1970	Kinetics of the reaction of hybrid-heme hemoglobins with carbon monoxide
Singh et al.	1982	Transport of gases in Pulmonary capillaries—a computation of equilibrium constants arising in the oxygen dissociation curve
BR9104995A (pt)	1992-06-23	Complexos ligados em ponte a hidrogenio,processo para sua preparacao e preparacao farmaceutica
MX9710114A (es)	1998-03-29	Ligandos de p-selectina y moleculas y metodos relacionados.